Fibroblast growth factor receptor 2 limits and receptor 1 accelerates tumorigenicity of prostate epithelial cells

Cancer Research

Volumn 57, Issue 23, 1997, Pages 5369-5378

  Feng, Shuju ^a   Wang, Fen ^a   Matsubara, Akio ^a,b   Kan, Mikio ^a   McKeehan, Wallace L ^a,c  

^a TEXAS A AND M UNIVERSITY   (United States)

^b HIROSHIMA UNIV SCHOOL OF MEDICINE   (Japan)

^c TEXAS A AND M HEALTH SCIENCE CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FIBROBLAST GROWTH FACTOR RECEPTOR;

ANIMAL CELL; ARTICLE; CARCINOGENICITY; CELL COMPARTMENTALIZATION; CELL DIFFERENTIATION; CELL POPULATION; EPITHELIUM CELL; GENETIC TRANSFECTION; NONHUMAN; PRIORITY JOURNAL; PROSTATE CARCINOMA; PROTEIN FAMILY; PROTEIN PHOSPHORYLATION; RAT; STROMA CELL; TUMOR GROWTH;

ANIMALS; CELL DIFFERENTIATION; CELL DIVISION; CELL LINE; CELL TRANSFORMATION, NEOPLASTIC; DISEASE PROGRESSION; DNA PRIMERS; EPITHELIAL CELLS; FIBROBLAST GROWTH FACTOR 2; KERATINS; MALE; POLYMERASE CHAIN REACTION; PRECANCEROUS CONDITIONS; PROSTATE; PROSTATIC NEOPLASMS; RATS; RECEPTOR PROTEIN-TYROSINE KINASES; RECEPTOR, FIBROBLAST GROWTH FACTOR, TYPE 1; RECEPTOR, FIBROBLAST GROWTH FACTOR, TYPE 2; RECEPTORS, FIBROBLAST GROWTH FACTOR; RECOMBINANT FUSION PROTEINS; RNA SPLICING; TRANSFECTION; TUMOR CELLS, CULTURED;

EID: 0030665570     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (35)

1. Isaacs, J. T. Development and characteristics of the available animal model systems for the study of prostatic cancer. In: N. Bruchovsky, W. A. Gardner, M. I. Resnick, P. P. Karr, and D. S. Coffey (eds.), Current Concepts and Approaches to the Study of Prostate Cancer, pp. 573-576. New York: Alan R. Liss, Inc., 1987.
2. Mansson, P. E., Adams, P., Kan, M., and McKeehan, W. L. Heparin-binding growth factor gene expression and receptor characteristics in normal rat prostate and two transplantable rat prostate tumors. Cancer Res., 49: 2485-2494, 1989.
3. McKeehan, W. L., Adams, P. S., and Fast, D. Different hormonal requirements for androgen-independent growth of normal and tumor epithelial cells from rat prostate. In Vitro Cell. Dev. Biol., 23: 147-152, 1987.
4. Xu, J., Nakahara, M., Crabb, J. W., Shi, E., Matuo, Y., Fraser, M., Kan, M., Hou, J., and McKeehan, W. L. Expression and immunochemical analysis of rat prostate and human heparin-binding fibroblast growth factor receptor (flg) isoforms. J. Biol. Chem., 267: 17792-17803, 1992.
5. Yan, G., Fukabori, Y., McBride, G., Nikolaropoulos, S., and McKeehan, W. L. Exon switching and activation of stromal and embryonic fibroblast growth factor (FGF)-FGF receptor genes in prostate epithelial cells accompany stromal independence and malignancy. Mol. Cell. Biol., 13: 4513-4522, 1993.
6. Yan, G., Fukabori, Y., Nikolaropoulos, S., Wang, F., and McKeehan, W. L. Heparin-binding keratinocyte growth factor (FGF-7) is a candidate stromal-to-epithelial cell prostate andromedin. Mol. Endocrinol., 6: 2123-2128, 1992.
7. Ornitz, D. M., Xu, J., Colvin, J. S., McEwen, D. G., MacArthur, C. A., Coulier, F., Gao, G., and Goldfarb, M. Receptor specificity of the fibroblast growth factor family. J. Biol. Chem., 271: 15292-15297, 1996.
8. Ornitz, D. M., and Leder, P. Ligand specificity and heparin dependence of fibroblast growth factor receptors 1 and 3. J. Biol. Chem., 267: 16305-16311, 1992.
9. Shaoul, E., Reich-Slotky, R., Berman, B., and Ron, D. Fibroblast growth factor receptors display both common and distinct signaling pathways. Oncogene, 10: 1553-1561, 1995.
10. Vainikka, S., Jouov, V., Wennstrom, S., Bergman, M., Pelicci, P. G., and Alitalo, K. Signal transduction by fibroblast growth factor receptor-4 (FGFR-4): comparison with FGFR-1. J. Biol. Chem., 269: 18320-18326, 1994.
11. Wang, J. K., Gao, G., and Goldfarb, M. Fibroblast growth factor receptors have different signaling and mitogenic potentials. Mol. Cell. Biol., 14: 181-188, 1994.
12. McKeehan, W. L., Adams, P. S., and Rosser, M. P. Direct mitogenic effects of insulin, epidermal growth factor, glucocorticoid, cholera toxin, unknown pituitary factors, and possibly prolactin, but not androgen on normal rat prostate epithelial cells in serum-free, primary cell culture. Cancer Res., 44: 1988-2010, 1984.
13. Wang, F., Kan, M., Xu, J., Yan, G., and McKeehan, W. L. Ligand-specific structural domains in the fibroblast growth factor receptor. J. Biol. Chem., 270: 10222-10230, 1995.
14. Wang, F., Kan, M., McKeehan, K., Feng, S., and McKeehan, W. L. A homeointeraction sequence in the ectodomain of the fibroblast growth factor receptor, J. Biol. Chem., 272: 23887-23895, 1997.
15. Kan, M., Shi, E., and McKeehan, W. L. Identification and assay of heparin-binding (fibroblast) growth factor receptors. Methods Enzymol., 198: 158-171, 1991.
16. Jang, J-H., Wang, F., and Kan, M. Heparan sulfate is required for interaction and activation of the epithelial cell fibroblast growth factor receptor-2IIIb with stromal-derived fibroblast growth factor-7. In Vitro Cell. Dev. Biol. Anim., in press, 1997.
17. 2-terminal fragment of FGF receptor isoforms R4 and R1α in human liver cells. Biochim. Biophys. Acta, 1310: 67-73, 1996.
18. Demedina, S. G. D., Chopin, D., Elmarjou, A., Delouvee, A., Larochelle, W. J., Hoznek, A., Abbou, C., Aaronson, S. A., Thiery, J. P., and Radvanyi, F. Decreased expression of keratinocyte growth factor receptor in a subset of human transitional cell bladder carcinomas. Oncogene, 14: 323-330, 1997.
19. Yan, G., Fukabori, Y., Nikolaropoulos, S., Wang, F., and McKeehan, W. L. Heparin-binding keratinocyte growth factor (FGF-7) is a candidate stromal-to-epithelial cell prostate andromedin. Mol. Endocrinol., 6: 2123-2128, 1992.
20. Jaye, M., Schlessinger, J., and Dionne, C. A. Fibroblast growth factor receptor tyrosine kinases: molecular analysis and signal transduction. Biochim. Biophys. Acta, 1135: 185-199, 1992.
21. Johnson, D. E., and Williams, L. T. Structural and functional diversity in the FGF receptor multigene family. Adv. Cancer Res., 60: 1-41, 1993.
22. Hou, J., McKeehan, K., Kan, M., Carr, S. A., Huddeston, M. J., Crabb, J. W., and McKeehan, W. L. Identification of tyrosines 154 and 307 in the extracellular domain and 653 and 766 in the intracellular domain as phosphorylation sites in the heparin-binding fibroblast growth factor receptor tyrosine kinase (flg). Protein Sci., 2: 86-92, 1993.
23. Mohammadi, M., Dikic, I., Sorokin, A., Burgess, W. H., Jaye, M., and Schlessinger, J. Identification of six novel autophosphorylation sites on fibroblast growth factor receptor 1 and elucidation of their importance in receptor activation and signal transduction. Mol. Cell. Biol., 16: 977-989, 1996.
24. Mohammadi, M., Honegger, A. M., Rotin, D., Fischer, R., Bellot, F., Li, W., Dionne, C. A., Jaye, M., Rubenstein, M., and Schlessinger, J. A tyrosine-phosphorylated carboxyl-terminal peptide of the fibroblast growth factor receptor (flg) is a binding site for the SH2 domain of phospholipase C-γ1. Mol. Cell. Biol., 11: 5068-5078, 1991.
25. Mohammadi, M., Dionne, C. A., Li, W., Spivak, T., Honegger, A. M., Jaye, M., and Schlessinger, J. Point mutation in FGF receptor eliminates phosphatidylinositol hydrolysis without affecting mitogenesis. Nature (Lond.), 358: 681-684, 1992.
26. 2+ flux but not mitogenesis. Nature (Lond.), 358: 678-681, 1992.
27. Spivak-Kroizman, T., Mohammadi, M., Hu, P., Jaye, M., Schlessinger, J., and Lax, I. Point mutation in the fibroblast growth factor receptor eliminates phosphatidylinositol hydrolysis without affecting neuronal differentiation of PC12 cells. J. Biol. Chem., 269: 14419-14423, 1994.
28. Wang, J. K., Li, H. C., and Goldfarb, M. Broadly expressed SNT-like proteins link FGF receptor stimulation to activators of Ras. Oncogene, 13: 721-729, 1996.
29. Goh, K. C., Lim, Y. P., Ong, S. H., Siak, C. B., Cao, X., Tan, Y. H., and Guy, G. R. Identification of p90, a prominent tyrosine-phosphorylated protein in fibroblast growth factor-stimulated cells, as 80K-H. J. Biol. Chem., 271: 5832-5838, 1996.
30. Ong, S. H., Goh, K. C., Lim, Y. P., Low, B. C., Klint, P., Claesson-Welch, L., Cao, X., Tan, Y. H., and Guy, G. R. SUC1-associated neurotrophic factor target (SNT) protein is a major FGF-stimulated tyrosine phosphorylation 90-kDa protein which binds to the SH2 domain of GRB2. Biochem. Biophys. Res. Commun., 225: 1021-1026, 1996.
31. Norbury, C., and Nurse, P. Animal cell cycles and their control. Annu. Rev. Biochem., 61: 441-470, 1992.
32. Rabin, S. J., Cleghon, V., and Kaplan, D. R. SNT, a differentiation-specific target of neurotrophic factor-induced tyrosine kinase activity in neurons and PC12 cells. Mol. Cell. Biol., 13: 2203-2213, 1993.
33. Su, W. C., Kitagawa, M., Xue, N., Xie, B., Garofalo, S., Cho, J., Deng, C., Horton, W. A., and Fu, X. Y. Activation of Stat1 by mutant fibroblast growth-factor receptor in thanatophoric dysplasia type II dwarfism. Nature (Lond.), 286: 288-292, 1997.
34. Kan, M., Wang, F., Kan, M., To, B., Gabriel, J., and McKeehan, W. L. Divalent cations and heparan sulfate cooperate to control assembly and activity of the fibroblast growth factor receptor complex. J. Biol. Chem., 271: 26143-26148, 1996.
35. Mohammadi, M., Schlessinger, J., and Hubbard, S. R. Structure of the FGF receptor tyrosine kinase domain reveals a novel autoinhibitory mechanism. Cell, 86: 577-587, 1996.